HIV/HBV/HCV Test Kits – Self-testing at Ease
Increasing efforts made by government and NGOs to raise awareness regarding HIV and viral hepatitis infections have worked to the advantage of the HIV/HBV/HCV test kits market. As new testing technologies and awareness campaigns have increased the uptake of HIV/HBV/HCV test kits among the patients, manufacturers are targeted towards developing innovative combination products that can detect HIV and hepatitis B & C together which can be next level of Hepatitis B Diagnostic Test and Hepatitis C Testing.
Global HIV/HBV/HCV Test Kits Market – Key Research Findings
Global HIV/HBV/HCV test kits market size in 2018 – nearly US$ 7 Bn.
The HIV/HBV/HCV test kits market is expected to grow at an approximate CAGR of 6.5% over 2019-2029.
North America and Europe are expected to remain the largest regional markets for HIV/HBV/HCV test kits products
North America and Europe are the leading regions in the HIV/HBV/HCV test kits market owing to the increasing adoption of HIV/HBV/HCV test kits for detection of infection and rising advancement & development of combination rapid test kits for detection of HIV and viral hepatitis b & C infection through the single cassette.
Manufacturers are majorly focusing on and delivering their products to regions such as Africa and Caribbean regions. Government organization and NGOs are raising awareness regarding HIV and viral hepatitis and encouraging them for testing which is expected to boost the growth of the HIV/HBV/HCV test kits market
Major players in the HIV/HBV/HCV test kits market, such as Abbott Laboratories, Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., bioMérieux SA, QIAGEN, Meridian Bioscience, Inc., Hologic Inc., Siemens AG, Maternova, Creative Diagnostics, and others.
The rapid test kit segment is expected to be the most lucrative test kit type.
The growth of this segment can be primarily attributed to the increasing demand for point-of-care diagnostics. Increasing adoption and raising awareness is the main reason for increasing demand and is expected to be the most preferred test kit type segment of the HIV/HBV/HCV test kits market in the coming years, which are expected to propel the growth of the HIV/HBV/HCV test kits market.
Top 2 Factors Shaping the HIV/HBV/HCV Test Kits Market
Rising Burden of HIV and Hepatitis around the World
The rising incidence of HIV and hepatitis is expected to boost the growth of the HIV/HBV/HCV test kits market around the world. HIV is one of the major public health issues globally. In 2017, an estimated 36.9 Mn people were living with HIV, of which 1.8 Mn were found to be children. The hepatitis B infection affected most of the African and Western Pacific Regions. The prevalence of hepatitis C was found to be prominent in the eastern Mediterranean and European regions. Untreated hepatitis B and hepatitis C infections can lead to serious complications of hepatocellular carcinoma and cirrhosis, which accounts for 470,000 and 720,000 annual deaths respectively. This factor is boosting the patient pool and increasing the market growth of HIV/HBV/HCV test kits market.
Campaigns and Programme to Raise Awareness and Encourage People for HIV/HBV/HCV Testing
A national communication campaign “HIV Treatment Works” encourages HIV patients to get and remain in care, start HIV medications, and follow treatment. This has contributed to the growth of the global HIV/HBV/HCV test kits market. The media team of American Institutes for Research closely works with CDC and provides nearly every major development regarding HIV/AIDS, STD, viral hepatitis, and tuberculosis to the population. The “We Can Stop HIV One Conversation at a Time” campaign encourages patients to talk independently about HIV. The campaign “Start Talking. Stop HIV”, raises awareness among bisexual men and gay. The governments, patient organizations, and the general public raised awareness regarding hepatitis and provided knowledge about disease prevention, access to testing, treatment, and care on “World Hepatitis Day”. These campaigns have largely contributed to the growth of the HIV/HBV/HCV test kits market.
HIV/HBV/HCV Test Kits Market Structure Analysis
The global HIV/HBV/HCV test kits market is a moderately consolidated market owing to the presence of major players
Some of the prominent companies in the HIV/HBV/HCV test kits market include Abbott Laboratories, Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., bioMérieux SA, QIAGEN, Meridian Bioscience, Inc., Hologic Inc., Siemens AG, Maternova, Creative Diagnostics, and others
Most of the key players in the HIV/HBV/HCV test kits market are emphasising on identifying and developing promising technologies and potential products from internal and external sources to meet the unmet needs of patients
The companies are focusing on collaborations to realise the potential of personalised healthcare as well as to enhance their pipeline in key disease areas
Market Set to Grow by 1.9X between 2019 and 2029
High prevalence of HIV and viral hepatitis infections, especially in low- and middle income countries, has been primarily contributing to the growth of the HIV/HBV/HCV test kits market. Future developments of the market are likely to go in hand with a global commitment to stop new infections and ensure that existing patients have access to advanced treatment.
Stakeholders to Tap Favourable Potential of Emerging Markets
Advanced healthcare systems, greater awareness among patients, and high demand for effective rapid diagnostic tests continue to make North America the largest market for HIV/HBV/HCV test kits. In addition to strengthening the product portfolios through R&D initiatives, key stakeholders are tapping into opportunities arising from low- and middle income countries where governments are employing prevention strategies of chronic diseases in association with WHO and CDC.
* This data is only a representation. Actual data may vary and will be available in report.
The Broader Perspective
Considering unmet needs of patients, manufacturers of HIV/HBV/HCV test kits are mainly focussed on discovery, development, and commercialization of innovative products. To stay competitive, market players are taking strategic initiatives to increase their product lines and expand their distribution in developing economies through acquisitions and collaborations with local distributors.
Assay-based test kits remain preferred, with nearly 70% revenue share
Demand for rapid test kits to witness promising growth
Tests performed onblood sample continue to gain marked preference
Use of urine sample for HIV/HBV/HCV testing to grow significantly
Use athospitals continues to remain significant
Adoption indiagnostic laboratories to increase at considerable rate
How Growth will Unfold
While assay-based test kits continue to maintain the lead position in the market, rapid test kits such as rapid test cards are expected to gain high popularity, for their ease of operations and quick results within two hours, typically in approximately 20 minutes.
Assay Based Test Kits | Rapid Test Kits
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
HIV/HBV/HCV Test Kits Market: Global Industry Analysis 2014–2018 and Forecast 2019–2029
A recent market study published by FMI “HIV/HBV/HCV Test Kits Market: Global Industry Analysis 2014–2018 and Forecast 2019–2029” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the HIV/HBV/HCV test kits market, the growth prospects of the market are obtained with maximum precision.
HIV/HBV/HCV Test Kits Market Taxonomy
The global HIV/HBV/HCV test kits market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
By Kit Types
- Assay-Based Test Kits
- Rapid Test Kits
- Assay-Based Test Kits
- Rapid Test Kits
- Assay-Based Test Kits
- Rapid Test Kits
- Combination Rapid Test Kits
By Sample Type
- For HIV, HBV, HCV and Combination Test Kits
By End User
- For HIV, HBV, HCV and Combination Test Kits
- Diagnostic Laboratories
- Government Organizations and NGO’s
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
- Emerging Countries
The report commences with the executive summary of the HIV/HBV/HCV test kits market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the HIV/HBV/HCV test kits market.
Readers can find the detailed taxonomy and the definition of the HIV/HBV/HCV test kits market in this chapter, which will help them understand the basic information about the HIV/HBV/HCV test kits market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the HIV/HBV/HCV test kits market report.
This section includes the key inclusions of the report. It includes the HIV & hepatitis B & C testing and the diagnostic strategy, patient journey, new HIV infected population, global average pricing analysis benchmark, consumer sentiment analysis, and value chain analysis, which are likely to contribute to market growth.
This section explains the global market value analysis and forecast for the HIV/HBV/HCV test kits market between the forecast period of 2014-2029. This chapter includes the detailed analysis of the historical HIV/HBV/HCV test kits market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019-2020), and an incremental opportunity for the forecast period (2019-2029).
This section highlights the average price of HIV, HBV, and HCV test kits in different regions across the globe.
This chapter explains the key macro-economic factors that are expected to influence the growth of the HIV/HBV/HCV test kits market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the HIV/HBV/HCV test kits market. This chapter also highlights the key market dynamics of the HIV/HBV/HCV test kits market, which include the drivers, restraints, and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the HIV/HBV/HCV test kits market.
Based on kit types, the HIV/HBV/HCV test kits market is segmented into assay-based test kits, rapid test kits, and combination rapid test kits. Readers can find information about the key trends and developments in the HIV/HBV/HCV test kits market and market attractiveness analysis based on the kit types.
Based on sample type, the HIV/HBV/HCV test kits market is segmented into blood, urine, and saliva. In this chapter, readers can find information about the key trends and developments in the HIV/HBV/HCV test kits market and market attractiveness analysis based on sample type used for the detection of HIV, HBV, and HCV infections.
This chapter provides details about the HIV/HBV/HCV test kits market on the basis of end user, and has been classified into hospitals, clinics, diagnostic laboratories, government organizations & NGOs, and others. In this chapter, readers can understand the market attractive analysis based on end user.
This chapter explains how the HIV/HBV/HCV test kits market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).
This chapter includes a detailed analysis of the growth of the North America, along with a country-wise assessment that includes the U.S. and Canada.
Readers can find detailed information about several factors, such as the pricing analysis, which are impacting the growth of the Latin America. This chapter also includes the growth prospects of the HIV/HBV/HCV test kits market in the leading LATAM countries such as Brazil, Mexico, and the Rest of Latin America.
Important growth prospects of the HIV/HBV/HCV test kits market based on its end users in several countries, such as Germany, the UK, France, Spain, Italy, Russia, and the Rest of Europe, are included in this chapter.
India, Indonesia, Thailand, and Malaysia are among the leading countries in the South Asia region, which are the prime subjects of assessment to obtain the growth prospects of the South Asia HIV/HBV/HCV test kits market in this chapter. Readers can find detailed information about the growth parameters of the South Asia HIV/HBV/HCV test kits market during the period 2019–2029.
This chapter highlights the growth of the HIV/HBV/HCV test kits market in East Asia by focusing on China, Japan, and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the HIV/HBV/HCV test kits market in East Asia.
In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania HIV/HBV/HCV test kits market.
This chapter provides information about how the HIV/HBV/HCV test kits market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, North Africa, and the rest of MEA, during the forecast period 2019 - 2029.
In this chapter, readers can find detailed information about the tier analysis and market concentration of the key players in the HIV/HBV/HCV test kits market, along with their market presence analysis by region and product portfolio.
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the HIV/HBV/HCV test kits market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Abbott Laboratories, Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., bioMérieux SA, QIAGEN, Meridian Bioscience, Inc., Hologic Inc., Siemens AG, Maternova, Creative Diagnostics, and others.
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the HIV/HBV/HCV test kits market report.
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the HIV/HBV/HCV test kits market.
How the research was conducted?
- C - Level Executives
- Marketing Directors
- Sales Heads
- Portfolio Managers
- Purchasing Managers
- Medical Officers
- Device Development Heads
- Strategy Advisors
- R&D Managers
- Product Manufacturers
- Component Suppliers / OEMs
- Hospital Purchasing Departments
- Physicians / Nursing Managers
- Industry Experts
- Current Market Dynamics and Challenges
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Product Adoption, Installed Base, Replacement Cycles, Refurbishment
- Regulatory Landscape
- Products in Pipeline and Clinical Development
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Industry Magazines
- American Academy of HIV Medicine
- Global HIV/AIDS Organizations
- Hepatitis B Foundation
- Hepatitis B & C Association
- Association of Nurses in AIDS Care
- The Joint United Nations Programme on HIV and AIDS
- Company Press Releases
- Annual Reports and Investor Presentations
- Peer-reviewed Journals
- Government Websites and Publications
- Trade Websites
- Clinical Trial Registries
- Country-specific Regulatory Authorities
- World Bank, WHO, OECD
Primary Interview Splits
HIV/HBV/HCV Test Kits Market Reports - Table of Contents
1. Executive Summary
19. Forecast Assumptions: Relevance and Impact
20. Forecast Factors: Relevance and Impact
22. Assumptions and Acronyms Used
23. Research Methodology